# Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy

> **NCT03575130** · PHASE2 · UNKNOWN · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 21 (estimated)

## Conditions studied

- Fuchs' Endothelial Dystrophy
- Fuchs Dystrophy
- Corneal Endothelial Dystrophy
- Corneal Endothelial Cell Loss
- Cornea Guttata

## Interventions

- **DRUG:** Ripasudil eye drops
- **DRUG:** Optive eye drops
- **PROCEDURE:** Descemetorhexis

## Key facts

- **NCT ID:** NCT03575130
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-05
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2018-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575130, "Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03575130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*